We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,756 hedge funds and large institutions have $252B invested in Johnson & Johnson in 2019 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 1,129 increasing their positions, 1,289 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 91 | Existing positions closed: 66

4.93% more ownership

Funds ownership: 68.05%72.98% (+4.9%)

0% less funds holding

Funds holding: 2,7662,756 (-10)

0% less capital invested

Capital invested by funds: $253B → $252B (-$1.14B)

7% less funds holding in top 10

Funds holding in top 10: 690639 (-51)

11% less call options, than puts

Call options by funds: $1.69B | Put options by funds: $1.9B

12% less repeat investments, than reductions

Existing positions increased: 1,129 | Existing positions reduced: 1,289

Holders
2,756
Holders Change
-10
Holders Change %
-0.36%
% of All Funds
59.85%
Holding in Top 10
639
Holding in Top 10 Change
-51
Holding in Top 10 Change %
-7.39%
% of All Funds
13.88%
New
91
Increased
1,129
Reduced
1,289
Closed
66
Calls
$1.69B
Puts
$1.9B
Net Calls
-$208M
Net Calls Change
+$260M
Name Holding Trade Value Shares
Change
Change in
Stake
FB
901
Fulton Bank
Pennsylvania
$8.31M -$412K -2,974 -5%
PP
902
Paloma Partners
Connecticut
$8.31M +$6.28M +45,359 +318%
AF
903
Arrow Financial
New York
$8.3M +$52.5K +379 +0.6%
PCMK
904
Paragon Capital Management (Kansas)
Kansas
$8.3M +$200K +1,448 +2%
ECM
905
Element Capital Management
New York
$8.29M +$6.89M +49,741 +508%
CYG
906
Clean Yield Group
Vermont
$8.28M +$143K +1,034 +2%
SAA
907
Southeast Asset Advisors
Georgia
$8.25M -$50K -361 -0.6%
VAS
908
Vestmark Advisory Solutions
Massachusetts
$8.24M -$237K -1,715 -3%
RGI
909
River Global Investors
United Kingdom
$8.22M -$1.31M -9,490 -14%
MRCM
910
M&R Capital Management
New Jersey
$8.21M -$29.8K -215 -0.4%
TIM
911
Thompson Investment Management
Wisconsin
$8.2M -$51.2K -370 -0.6%
WRM
912
Weybosset Research & Management
Rhode Island
$8.2M +$30.2K +218 +0.4%
SCM
913
Schnieders Capital Management
California
$8.2M +$131K +944 +2%
BCM
914
Blume Capital Management
California
$8.18M -$56.8K -410 -0.7%
TFA
915
Toth Financial Advisory
Virginia
$8.17M +$331K +2,391 +4%
LNC
916
Lincoln National Corp
Pennsylvania
$8.15M +$3.48M +25,147 +75%
FNF
917
Fidelity National Financial
Florida
$8.14M
RB
918
Rodgers Brothers
Pennsylvania
$8.13M -$20.8K -150 -0.3%
GIP
919
Granite Investment Partners
California
$8.13M -$46.4K -335 -0.6%
WWM
920
Willingdon Wealth Management
North Carolina
$8.11M -$109K -788 -1%
RPC
921
Rossmore Private Capital
Connecticut
$8.09M +$89.3K +645 +1%
FVSAZ
922
Flossbach von Storch AG Zurich
Switzerland
$8.07M
VIP
923
Vantage Investment Partners
Missouri
$8.06M -$1.58M -11,431 -16%
OPTFSNA
924
Old Point Trust & Financial Services N A
Virginia
$8.06M -$106K -763 -1%
ECM
925
ETrade Capital Management
Virginia
$8.06M -$234K -1,689 -3%

JNJ Hedge Fund Activity: Q2 2019 in Review

2,756 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2019, worth a combined $252B — down 0.45% from $253B a quarter earlier.

Buyers outnumbered sellers: 91 funds opened new JNJ positions and 66 closed out — a net gain of 25 holders — while 1,129 added to existing stakes and 1,289 trimmed.

The largest buyer was Phocas Financial Corp, adding an estimated $17.3B. The largest seller was Barrow, Hanley, Mewhinney & Strauss, cutting an estimated $719M.

  • 2,756 institutional investors held Johnson & Johnson (JNJ) as of Q2 2019, down from 2,766 in Q1 2019.
  • Funds reported $252B of Johnson & Johnson stock for Q2 2019, down 0.45% quarter-over-quarter.
  • 91 funds opened new Johnson & Johnson positions in Q2 2019 and 66 closed out, a net change of +25 holders.
  • The largest Johnson & Johnson buyer in Q2 2019 was Phocas Financial Corp, an estimated $17.3B added.
  • The largest Johnson & Johnson seller in Q2 2019 was Barrow, Hanley, Mewhinney & Strauss, an estimated $719M sold.

Based on aggregated 13F filings for Q2 2019.